| 0 |
PERIPANCREATIC FLUID COLLECTION |
1 |
0.0066 |
| 1 |
PANCREATIC CARCINOMA RECURRENT |
1 |
0.0041 |
| 2 |
POST PROCEDURAL BILE LEAK |
1 |
0.0032 |
| 3 |
PSEUDOCYST |
1 |
0.0031 |
| 4 |
TONGUE PRURITUS |
1 |
0.0012 |
| 5 |
ABDOMINAL SEPSIS |
1 |
0.0011 |
| 6 |
HEART TRANSPLANT |
1 |
0.0011 |
| 7 |
MOANING |
1 |
0.0009 |
| 8 |
HYPORESPONSIVE TO STIMULI |
1 |
0.0009 |
| 9 |
PERIPHERAL ARTERY THROMBOSIS |
1 |
0.0007 |
| 10 |
TONIC CONVULSION |
1 |
0.0007 |
| 11 |
PANCREATITIS NECROTISING |
1 |
0.0004 |
| 12 |
INTRA-ABDOMINAL HAEMORRHAGE |
1 |
0.0004 |
| 13 |
METABOLIC ENCEPHALOPATHY |
1 |
0.0003 |
| 14 |
OEDEMA MOUTH |
1 |
0.0003 |
| 15 |
LIVER TRANSPLANT |
1 |
0.0003 |
| 16 |
TONGUE OEDEMA |
1 |
0.0003 |
| 17 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
0.0002 |
| 18 |
LIP OEDEMA |
1 |
0.0002 |
| 19 |
OCULAR ICTERUS |
1 |
0.0002 |
| 20 |
LUMBAR VERTEBRAL FRACTURE |
1 |
0.0002 |
| 21 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 22 |
MYASTHENIA GRAVIS |
1 |
0.0001 |
| 23 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 24 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 25 |
LEUKAEMIA |
1 |
0.0001 |
| 26 |
RECALLED PRODUCT ADMINISTERED |
1 |
0.0001 |
| 27 |
HOSPICE CARE |
1 |
0.0001 |
| 28 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 29 |
BRAIN INJURY |
1 |
0.0001 |
| 30 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 31 |
PANCREATITIS ACUTE |
2 |
0.0001 |
| 32 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 33 |
SPINAL PAIN |
1 |
0.0001 |
| 34 |
DIALYSIS |
1 |
0.0001 |
| 35 |
COLON CANCER |
1 |
0.0001 |
| 36 |
INSURANCE ISSUE |
1 |
0.0001 |
| 37 |
CYANOSIS |
1 |
0.0001 |
| 38 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 39 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 40 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 41 |
NEUROTOXICITY |
1 |
0.0001 |
| 42 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 43 |
GOUT |
1 |
0.0001 |
| 44 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 45 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 46 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 47 |
PREGNANCY |
1 |
0.0000 |
| 48 |
INTENTIONAL SELF-INJURY |
1 |
0.0000 |
| 49 |
RIB FRACTURE |
1 |
0.0000 |
| 50 |
PERITONITIS |
1 |
0.0000 |
| 51 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 52 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 53 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 54 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 55 |
LOCALISED INFECTION |
1 |
0.0000 |
| 56 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 57 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 58 |
DIPLOPIA |
1 |
0.0000 |
| 59 |
JAUNDICE |
1 |
0.0000 |
| 60 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 61 |
PNEUMONITIS |
1 |
0.0000 |
| 62 |
CARDIAC ARREST |
3 |
0.0000 |
| 63 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 64 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 65 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 66 |
LIP SWELLING |
1 |
0.0000 |
| 67 |
HAEMATURIA |
1 |
0.0000 |
| 68 |
RASH MACULAR |
1 |
0.0000 |
| 69 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 70 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 71 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 72 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 73 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 74 |
SEPTIC SHOCK |
1 |
0.0000 |
| 75 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 76 |
SYNCOPE |
2 |
0.0000 |
| 77 |
FLUID RETENTION |
1 |
0.0000 |
| 78 |
THERAPY CESSATION |
1 |
0.0000 |
| 79 |
SPEECH DISORDER |
1 |
0.0000 |
| 80 |
DRUG INTERACTION |
3 |
0.0000 |
| 81 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 82 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 83 |
NECK PAIN |
1 |
0.0000 |
| 84 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 85 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 86 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 87 |
DYSPHONIA |
1 |
0.0000 |
| 88 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 89 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 90 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 91 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 92 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 93 |
CONSTIPATION |
3 |
0.0000 |
| 94 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 95 |
AGITATION |
1 |
0.0000 |
| 96 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 97 |
HOSPITALISATION |
2 |
0.0000 |
| 98 |
THROMBOSIS |
1 |
0.0000 |
| 99 |
DRY MOUTH |
1 |
0.0000 |
| 100 |
TREATMENT FAILURE |
1 |
0.0000 |
| 101 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 102 |
DYSPHAGIA |
1 |
0.0000 |
| 103 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 104 |
HAEMORRHAGE |
1 |
0.0000 |
| 105 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 106 |
PALPITATIONS |
1 |
0.0000 |
| 107 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 108 |
DEATH |
7 |
0.0000 |
| 109 |
HYPERHIDROSIS |
1 |
0.0000 |
| 110 |
MALAISE |
3 |
0.0000 |
| 111 |
TREMOR |
1 |
0.0000 |
| 112 |
COVID-19 |
1 |
0.0000 |
| 113 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 114 |
ASTHENIA |
2 |
0.0000 |
| 115 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 116 |
DECREASED APPETITE |
1 |
0.0000 |
| 117 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 118 |
FEELING ABNORMAL |
1 |
0.0000 |
| 119 |
COUGH |
1 |
0.0000 |
| 120 |
PRURITUS |
1 |
0.0000 |
| 121 |
FATIGUE |
2 |
0.0000 |
| 122 |
OFF LABEL USE |
2 |
0.0000 |
| 123 |
VOMITING |
1 |
0.0000 |
| 124 |
DIZZINESS |
1 |
0.0000 |
| 125 |
DYSPNOEA |
1 |
0.0000 |
| 126 |
DIARRHOEA |
1 |
0.0000 |
| 127 |
NAUSEA |
1 |
0.0000 |